Ionis Pharmaceuticals Inc.

About Ionis Pharmaceuticals Inc.

Ionis Pharmaceuticals is dedicated to unlocking the potential of RNA- and DNA-targeted medicines to create better futures for people with serious diseases. Their mission is to change the course of human health by delivering groundbreaking solutions for patients and caregivers, driven by a deep understanding of genetics and a commitment to transformative impact.

Products & Services

RNA- and DNA-Targeted Medicines:Innovative therapies designed to address serious diseases by targeting genetic mechanisms.

TRYNGOLZA (olezarsen):Approved in the EU for the treatment of familial chylomicronemia syndrome (FCS) in adults as an adjunct to diet.

Zilganersen:An investigational medicine for Alexander disease, showing clinically meaningful and disease-modifying impact, with NDA submission planned for Q1 2026.

Specialties

RNA-targeted therapies DNA-targeted therapies Genetics-based drug development Neurological disease treatments Cardiometabolic disorder treatments

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Public Offering T: - FT: Public Offering	A: 500000000 MR: - FA: $500.0 million FAN: 500000000	D: 2024-09-09 FD: 2024-09-09	2 investors
2	RT: Public Offering T: - FT: Public Offering	A: 500300000 MR: - FA: 500.3 million FAN: 500300000	D: 2024-09-09 FD: 2024-09-09	2 investors
3	RT: Private Placement of Convertible Notes T: - FT: Private Placement of Convertible Notes	A: 500000000 MR: - FA: 500.0 million FAN: 500000000	D: 2023-06-06 FD: 2023-06-06	-

Public Offering Latest

2024-09-09

$500.0M

2 investors (Pro only)

Public Offering 2024-09-09

$500.3M

Private Placement of Convertible Notes 2023-06-06

$500.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Brett P. Monia

Chief Executive Officer

S

Stanley T. Crooke

B

Brian Birchler

Executive Vice President, Corporate and Development Operations

C

C. Frank Bennett

Executive Vice President, Chief Scientific Officer

E

Elizabeth L. Hougen

Executive Vice President, Chief Financial Officer

E

Eric E. Swayze

Executive Vice President, Research

View 75 more team members with Pro

Unlock Full Team Directory

Recent News